Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial.
Gilbody S, Peckham E, Bailey D, Arundel C, Heron P, Crosland S, Fairhurst C, Hewitt C, Li J, Parrott S, Bradshaw T, Horspool M, Hughes E, Hughes T, Ker S, Leahy M, McCloud T, Osborn D, Reilly J, Steare T, Ballantyne E, Bidwell P, Bonner S, Brennan D, Callen T, Carey A, Colbeck C, Coton D, Donaldson E, Evans K, Herlihy H, Khan W, Nyathi L, Nyamadzawo E, Oldknow H, Phiri P, Rathod S, Rea J, Romain-Hooper CB, Smith K, Stribling A, Vickers C. Gilbody S, et al. Among authors: ballantyne e. Lancet Psychiatry. 2019 May;6(5):379-390. doi: 10.1016/S2215-0366(19)30047-1. Epub 2019 Apr 8. Lancet Psychiatry. 2019. PMID: 30975539 Free PMC article. Clinical Trial.
A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
Peckham E, Arundel C, Bailey D, Crosland S, Fairhurst C, Heron P, Hewitt C, Li J, Parrott S, Bradshaw T, Horspool M, Hughes E, Hughes T, Ker S, Leahy M, McCloud T, Osborn D, Reilly J, Steare T, Ballantyne E, Bidwell P, Bonner S, Brennan D, Callen T, Carey A, Colbeck C, Coton D, Donaldson E, Evans K, Herlihy H, Khan W, Nyathi L, Nyamadzawo E, Oldknow H, Phiri P, Rathod S, Rea J, Romain-Hooper CB, Smith K, Stribling A, Vickers C, Gilbody S. Peckham E, et al. Among authors: ballantyne e. Health Technol Assess. 2019 Sep;23(50):1-116. doi: 10.3310/hta23500. Health Technol Assess. 2019. PMID: 31549622 Free PMC article. Clinical Trial.
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1).
Simon JA, Anderson RA, Ballantyne E, Bolognese J, Caetano C, Joffe H, Kerr M, Panay N, Seitz C, Seymore S, Trower M, Zuurman L, Pawsey S. Simon JA, et al. Among authors: ballantyne e. Menopause. 2023 Mar 1;30(3):239-246. doi: 10.1097/GME.0000000000002138. Epub 2023 Jan 30. Menopause. 2023. PMID: 36720081 Free PMC article. Clinical Trial.
Meeting sustainable development goals via robotics and autonomous systems.
Guenat S, Purnell P, Davies ZG, Nawrath M, Stringer LC, Babu GR, Balasubramanian M, Ballantyne EEF, Bylappa BK, Chen B, De Jager P, Del Prete A, Di Nuovo A, Ehi-Eromosele CO, Eskandari Torbaghan M, Evans KL, Fraundorfer M, Haouas W, Izunobi JU, Jauregui-Correa JC, Kaddouh BY, Lewycka S, MacIntosh AC, Mady C, Maple C, Mhiret WN, Mohammed-Amin RK, Olawole OC, Oluseyi T, Orfila C, Ossola A, Pfeifer M, Pridmore T, Rijal ML, Rega-Brodsky CC, Robertson ID, Rogers CDF, Rougé C, Rumaney MB, Seeletso MK, Shaqura MZ, Suresh LM, Sweeting MN, Taylor Buck N, Ukwuru MU, Verbeek T, Voss H, Wadud Z, Wang X, Winn N, Dallimer M. Guenat S, et al. Among authors: ballantyne eef. Nat Commun. 2022 Jun 21;13(1):3559. doi: 10.1038/s41467-022-31150-5. Nat Commun. 2022. PMID: 35729171 Free PMC article.
56 results